Jyong Biotech Ltd. (Revived IPO) (MENS) is planning to raise $22 million in an initial public offering (IPO) on Thursday, April 3rd, IPO Scoop reports. The company plans to issue 2,700,000 shares at ...
Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Thursday, April 3rd, IPO Scoop reports. The company will be issuing 2,700,000 shares at $7.50-$8.50 per share. The ...
Dowling outlined three strategic growth areas: product innovation, cost-efficiency improvements, and M&A activities. He highlighted the launch of the Plus Health product line, which includes ...
This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...
As a contract research and development biotechnology firm, CD Formulation establishes new benchmarks for health care product development by delivering extensive product formulation services. From ...
Research Institute to advance nutraceutical product development across four core research areas17/03/25, SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing ...
According to the latest study from BCC Research, "Softgel Capsules: Global Markets" is expected to grow from $7.9 billion in 2024 to $11.5 billion by the end of 2029, at a compound annual growth rate ...
"Innovative Softgel Capsules Enhance Drug Delivery and Nutrient Absorption, Revolutionizing the Pharmaceutical and Nutraceutical Industries with Controlled Release, Increased Bioavailability ...
The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. Though extremely common amongst athletes and exercise ...
Ever-Growing USA on MSN16d
Packaging Production Line: A Comprehensive GuideIn the ever-evolving world of manufacturing and packaging, efficiency, precision, and innovation drive the industry forward. A packaging production line is an essential component of modern ...
Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...
March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback